Mereo BioPharma Group plc (FRA:MAH0)
Germany · Delayed Price · Currency is EUR 1.595
+0.065 (4.25%)
Nov 25, 2025, 4:00 PM EST
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of €251.87 million as of December 1, 2025. Its market cap has decreased by -57.92% in one year.
Market Cap
251.87M
Enterprise Value
210.32M
Revenue
426.15K
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.60
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has increased from 111.54M to 251.87M, an increase of 125.81%. That is a compound annual growth rate of 13.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 256.63M | -50.99% |
| Dec 31, 2024 | 523.66M | 78.98% |
| Dec 29, 2023 | 292.57M | 257.14% |
| Dec 30, 2022 | 81.92M | -46.41% |
| Dec 31, 2021 | 152.86M | -22.61% |
| Dec 31, 2020 | 197.54M | 244.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |